Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Oncotarget
|
March 9, 2018
CXCR4: A new player in vestibular schwannoma pathogenesis
Maria Breun, Alexandra Schwerdtfeger, Donato Daniel Martellotta, et al.
Bioorganic & Medicinal Chemistry
|
May 28, 2013
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma
Harun M Said, Carsten Hagemann, Fabrizio Carta, et al.
Cancers
|
November 11, 2022
Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
Vera Nickl, Ellina Schulz, Ellaine Salvador, et al.
Frontiers in Oncology
|
May 31, 2024
Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
Vera Nickl, David Ziebolz, Charlotte Rumpel, et al.
Cancers
|
June 10, 2023
BRMS1 in Gliomas-An Expression Analysis
Jonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Cancer Research
|
July 15, 2022
The Mechanisms of Action of Tumor Treating Fields
Justin C Moser, Ellaine Salvador, Karina Deniz, et al.
International Journal of Molecular Sciences
|
July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients
Jonas Feldheim, David Wend, Mara J Lauer, et al.
Cancers
|
August 26, 2023
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic
Jonas Feldheim, Teresa Schmidt, Christoph Oster, et al.
International Journal of Molecular Medicine
|
December 17, 2008
RAF expression in human astrocytic tumors
Carsten Hagemann, Jens Gloger, Jelena Anacker, et al.
Cancers
|
June 16, 2019
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
Carsten Hagemann, Nikolas Neuhaus, Mathias Dahlmann, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Oncotarget
|
March 9, 2018
CXCR4: A new player in vestibular schwannoma pathogenesis
Maria Breun, Alexandra Schwerdtfeger, Donato Daniel Martellotta, et al.
Bioorganic & Medicinal Chemistry
|
May 28, 2013
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma
Harun M Said, Carsten Hagemann, Fabrizio Carta, et al.
Cancers
|
November 11, 2022
Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
Vera Nickl, Ellina Schulz, Ellaine Salvador, et al.
Frontiers in Oncology
|
May 31, 2024
Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
Vera Nickl, David Ziebolz, Charlotte Rumpel, et al.
Cancers
|
June 10, 2023
BRMS1 in Gliomas-An Expression Analysis
Jonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Cancer Research
|
July 15, 2022
The Mechanisms of Action of Tumor Treating Fields
Justin C Moser, Ellaine Salvador, Karina Deniz, et al.
International Journal of Molecular Sciences
|
July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients
Jonas Feldheim, David Wend, Mara J Lauer, et al.
Cancers
|
August 26, 2023
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic
Jonas Feldheim, Teresa Schmidt, Christoph Oster, et al.
International Journal of Molecular Medicine
|
December 17, 2008
RAF expression in human astrocytic tumors
Carsten Hagemann, Jens Gloger, Jelena Anacker, et al.
Cancers
|
June 16, 2019
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
Carsten Hagemann, Nikolas Neuhaus, Mathias Dahlmann, et al.
Page
of 7